Ming‐Szu Hung - Concepedia

Author

Ming‐Szu Hung

Chiayi Chang Gung Memorial Hospital ORCID

Also Known As

M. Hung, MING-SZU HUNG, Ming-Szu Hung, Ming-Szu Hung Hung, Ming‐Szu HUNG, Ming‐Szu Hung, Ming‑Szu Hung

Publications

1.3K

Citations

H-Index

Concepts

All Affiliations

Chiayi Chang Gung Memorial Hospital Chang Gung University Chang Gung University of Science and Technology Chang Gung Memorial Hospital University of California, San Francisco

About

Ming‐Szu Hung is an author at Chiayi Chang Gung Memorial Hospital specializing in medicine, tumor biology, and tumor microenvironment.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	13	557
2	Cell Biology	9	9	344
3	Natural Sciences	1	1	14
4	Biochemistry	1	1	14
5	Epidemiology	1	1	167

Ming‐Szu Hung

Publications

1.2K

Citations

H-Index

Page 1

	Year	Citations
Risk scoring systems to predict need for clinical intervention for patients with nonvariceal upper gastrointestinal tract bleeding I‐Chuan Chen, Ming‐Szu Hung, Te‐Fa Chiu, The American Journal of Emergency Medicine Gastrointestinal BleedingPrognostic EvaluationDisease Risk AssessmentPrognosisPatient Safety	2007	167
Promoter demethylation of WIF-1 by epigallocatechin-3-gallate in lung cancer cells. Zhi Gao, Zhidong Xu, Ming‐Szu Hung, PubMed	2009	123
Statin improves survival in patients with EGFR-TKI lung cancer: A nationwide population-based study Ming‐Szu Hung, I‐Chuan Chen, Chuan-Pin Lee, PLoS ONE	2017	80
Epidermal growth factor receptor mutation enhances expression of vascular endothelial growth factor in lung cancer Ming‐Szu Hung, I‐Chuan Chen, Paul-Yann Lin, Oncology Letters AngiogenesisTumor MicroenvironmentMedicineNsclc TissuesCancer Growth	2016	76
Cul4A is an oncogene in malignant pleural mesothelioma Ming‐Szu Hung, Jian‐Hua Mao, Zhidong Xu, Journal of Cellular and Molecular Medicine Malignant Pleural MesotheliomaMalignant DiseaseMedicinePathologyPleural Disease	2009	70
Frizzled-8 receptor is activated by the Wnt-2 ligand in non-small cell lung cancer Dawn T. Bravo, Yi‐Lin Yang, Kristopher Kuchenbecker, BMC Cancer Wnt-2 SignalingLung InflammationPathologyCancer BiologyTumor Biology	2013	48
<p>Concurrent proton-pump inhibitors increase risk of death for lung cancer patients receiving 1st-line gefitinib treatment - a nationwide population-based study</p> Yu‐Hung Fang, Yao‐Hsu Yang, Meng‐Jer Hsieh, Cancer Management and Research	2019	39
Epidermal growth factor receptor mutations in cells from non-small cell lung cancer malignant pleural effusions. Ming‐Szu Hung, Chin‐Kuo Lin, Shaw‐Woei Leu, PubMed	2006	37
Pulmonary cryptococcosis: Clinical, radiographical and serological markers of dissemination Ming‐Szu Hung, Ying‐Huang Tsai, Cheng‐Hui LEE, Respirology	2007	35
Functional Polymorphism of the CK2α Intronless Gene Plays Oncogenic Roles in Lung Cancer Ming‐Szu Hung, Yu‐Ching Lin, Jian‐Hua Mao, PLoS ONE	2010	34

Page 1